Harmony Biosciences Holdings (HRMY) Shares Outstanding (Diluted Average) (2019 - 2026)

Harmony Biosciences Holdings has disclosed Shares Outstanding (Diluted Average) across 8 years of filings, most recently posting $58.8 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $58.8 million, changed 0.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $58.8 million (changed 0.43% YoY), and the FY2025 annual result was $58.5 million, up 1.17% from the prior year.
• Shares Outstanding (Diluted Average) came in at $58.8 million for Q1 2026 at Harmony Biosciences Holdings, roughly flat from $58.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $61.2 million in Q1 2023 to a low of $57.5 million in Q2 2024.
• The 5-year median for Shares Outstanding (Diluted Average) is $58.8 million (2026), against an average of $59.4 million.
• Across the five-year window, Shares Outstanding (Diluted Average) rose 3.98% in 2022 and dropped 5.92% in 2024, its largest moves.
• Harmony Biosciences Holdings' Shares Outstanding (Diluted Average) stood at $61.1 million in 2022, then declined by 1.19% to $60.4 million in 2023, then decreased by 4.15% to $57.9 million in 2024, then climbed by 1.17% to $58.5 million in 2025, then rose by 0.4% to $58.8 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $58.8 million (Q1 2026), $58.5 million (Q4 2025), and $58.7 million (Q3 2025), per Business Quant data.